Literature DB >> 3620228

The course of idiopathic dilated cardiomyopathy in New Zealand.

H Ikram, H G Williamson, M Won, I G Crozier, E J Wells.   

Abstract

The course of dilated cardiomyopathy in New Zealand was studied in 72 cases that were followed up for less than or equal to 10 years after cardiac catheterisation and coronary angiography. Eighty one per cent were male and 86% were white; the remainder were Maori. The mean age of patients at the time of investigation was 50 X 15 years. Most patients were unskilled labourers. The commonest presenting symptom was dyspnoea and the commonest physical sign was cardiomegaly. Mean survival time from first hospital presentation was 85 months; half the deaths were sudden. Factors predicting a poor survival included cardiomegaly, age, arrhythmias, cigarette smoking, and subclinical thiamine deficiency. The syndrome of dilated cardiomyopathy in New Zealand appears to be identical with that seen in other European populations.

Entities:  

Mesh:

Year:  1987        PMID: 3620228      PMCID: PMC1277221          DOI: 10.1136/hrt.57.6.521

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  31 in total

1.  ALCOHOLIC HEART DISEASE.

Authors:  W BRIGDEN; J ROBINSON
Journal:  Br Med J       Date:  1964-11-21

2.  Left-ventricular endomyocardial biopsy.

Authors:  I A Brooksby; B S Jenkins; D J Coltart; M M Webb-Peploe; M J Davies
Journal:  Lancet       Date:  1974-11-23       Impact factor: 79.321

3.  Effects of carbon monoxide on myocardium. Ultrastructural changes in rabbits after moderate, chronic exposure.

Authors:  K Kjeldsen; H K Thomsen; P Astrup
Journal:  Circ Res       Date:  1974-03       Impact factor: 17.367

4.  A method of left ventricular ejection fraction estimation from cineangiocardiograms employing a special-purpose calculator.

Authors:  P J Bones; H Ikram
Journal:  Cardiovasc Res       Date:  1977-09       Impact factor: 10.787

5.  Effect of vasodilators on survival in chronic congestive heart failure.

Authors:  C D Furberg; S Yusuf
Journal:  Am J Cardiol       Date:  1985-04-01       Impact factor: 2.778

6.  Prognosis and possible presymptomatic manifestations of congestive cardiomyopathy (COCM).

Authors:  H Kuhn; G Breithardt; H J Knieriem; E Köhler; B Lösse; L Seipel; F Loogen
Journal:  Postgrad Med J       Date:  1978-07       Impact factor: 2.401

7.  The Canterbury alcoholism screening test (CAST): a detection instrument for use with hospitalised patients.

Authors:  G A Elvy; J E Wells
Journal:  N Z Med J       Date:  1984-02-22

8.  Mildly dilated congestive cardiomyopathy.

Authors:  A Keren; M E Billingham; D Weintraub; E B Stinson; R L Popp
Journal:  Circulation       Date:  1985-08       Impact factor: 29.690

9.  Determinants of survival in patients with congestive cardiomyopathy: quantitative morphologic findings and left ventricular hemodynamics.

Authors:  F Schwarz; G Mall; H Zebe; E Schmitzer; J Manthey; H Scheurlen; W Kübler
Journal:  Circulation       Date:  1984-12       Impact factor: 29.690

10.  Chronic myocardial disease. I. Clinical picture related to long-term prognosis.

Authors:  L Hatle; O Orjavik; O Storstein
Journal:  Acta Med Scand       Date:  1976
View more
  7 in total

1.  Left ventricular end-systolic stress/diameter relation as a contractility index and as a predictor of survival. Independence of preload after normalization for end-diastolic diameter.

Authors:  Ioannis Moyssakis; Nikitas Moschos; Filipos Triposkiadis; Youssef Hallaq; Nick Pantazopoulos; Athanasios Aessopos; Miltiades Kolettis
Journal:  Heart Vessels       Date:  2005-09       Impact factor: 2.037

2.  Left atrial size is the major predictor of cardiac death and overall clinical outcome in patients with dilated cardiomyopathy: a long-term follow-up study.

Authors:  M G Modena; N Muia; F A Sgura; R Molinari; A Castella; R Rossi
Journal:  Clin Cardiol       Date:  1997-06       Impact factor: 2.882

3.  Low dose dobutamine stress echocardiography predicts the improvement of left ventricular systolic function in dilated cardiomyopathy.

Authors:  H Kitaoka; J Takata; T Yabe; N Hitomi; T Furuno; Y L Doi
Journal:  Heart       Date:  1999-05       Impact factor: 5.994

4.  Changing mortality in dilated cardiomyopathy. The Heart Muscle Disease Study Group.

Authors:  A Di Lenarda; G Secoli; A Perkan; D Gregori; G Lardieri; B Pinamonti; G Sinagra; M Zecchin; F Camerini
Journal:  Br Heart J       Date:  1994-12

5.  The usefulness of age and sex to predict all-cause mortality in patients with dilated cardiomyopathy: a single-center cohort study.

Authors:  Xiaoping Li; Chi Cai; Rong Luo; Rongjian Jiang; Jie Zeng; Yijia Tang; Yang Chen; Michael Fu; Tao He; Wei Hua
Journal:  Clin Interv Aging       Date:  2015-09-16       Impact factor: 4.458

Review 6.  Sex Differences, Genetic and Environmental Influences on Dilated Cardiomyopathy.

Authors:  Angita Jain; Nadine Norton; Katelyn A Bruno; Leslie T Cooper; Paldeep S Atwal; DeLisa Fairweather
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

7.  The effects of smoking and drinking on all-cause mortality in patients with dilated cardiomyopathy: a single-center cohort study.

Authors:  Xiaoping Li; Yang Liu; Rong Luo; Gang Li; Peng Luo; MingJiang Liu; Tao He; Wei Hua
Journal:  Eur J Med Res       Date:  2015-09-17       Impact factor: 2.175

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.